Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 216

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 216
---
) file or caused to be filed
any registration statement with the SEC relating to the offering of any Class A Ordinary Shares of the Company or any securities convertible
into or exercisable or exchangeable for Class A Ordinary Shares of the Company.

Each of our officers, directors, and all existing
shareholders who own 5% or more of the issued and outstanding Class A Ordinary Shares after this Offering agree not to offer, issue,
sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any Class A Ordinary Shares or other securities
convertible into or exercisable or exchangeable for Class A Ordinary Shares for up to six (6) months from the closing date of this
offering, without the prior written consent of the Representative.

The Representative may in its sole discretion
and at any time without notice release some or all of the shares subject to lock-up agreements prior to the expiration of the lock-up
period. When determining whether or not to release shares from the lock-up agreements, the Representative will consider, among other
factors, the security holder’s reasons for requesting the release, the number of shares for which the release is being requested
and market conditions at the time.

Application for Nasdaq Listing

We applied to have our Class A Ordinary Shares approved for listing/quotation on the Nasdaq Capital Market under the symbol “LHI.” We will not consummate and close this Offering without a listing approval letter from the Nasdaq Capital Market. Our receipt of a listing approval letter is not the same as an actual listing on the Nasdaq Capital Market. The listing approval letter will serve only to confirm that, if we sell a number of Class A Ordinary Shares in this Offering sufficient to satisfy applicable listing criteria, our Class A Ordinary Shares will in fact be listed.

If our Class A Ordinary Shares are listed on
the Nasdaq Capital Market, we will be subject to continued listing requirements and corporate governance standards. We expect these new
rules and regulations to significantly increase our legal, accounting and financial compliance costs.

Passive Market Making

Any underwriter who is a qualified market maker
on Nasdaq may engage in passive market making transactions on Nasdaq, in accordance with Rule 103 of Regulation M under the
Exchange Act, during a period before the commencement of offers or sales of the shares and extending through the completion of the
distribution. Passive market makers must comply with applicable volume and price limitations and must be identified as a passive market
maker. In general, a passive market maker must